Open AccessYOSEMITE and RHINE
Author(s) -
Nicole Eter,
Rishi P. Singh,
Francis Abreu,
Kemal Asik,
Karen Basu,
Caroline R. Baumal,
Andrew Chang,
Karl G. Csaky,
Zdenka Hašková,
Hugh Lin,
Carlos Quezada-Ruiz,
Paisan Ruamviboonsuk,
David G. Silverman,
Charles C. Wykoff,
Jeffrey R. Willis
Publication year - 2021
Publication title -
ophthalmology science
Language(s) - English
Resource type - Journals
ISSN - 2666-9145
DOI - 10.1016/j.xops.2021.100111
Subject(s) - aflibercept , medicine , clinical endpoint , dosing , bevacizumab , adverse effect , regimen , clinical trial , surgery , chemotherapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom